The logo of Celltrion is seen at the company's headquarters in Incheon, South Korea. South Korea expects clinical trials of Celltrion Inc's experimental Covid-19 treatment to begin in Europe next month and aims to secure sizable supplies of the drug by next year, a senior health official said on Tuesday (June 2). - Reuters
SEOUL(Reuters): South Korea expects clinical trials of Celltrion Inc's experimental Covid-19 (coronavirus) treatment to begin in Europe next month and aims to secure sizeable supplies of the drug by the first half of next year, a senior health official said on Tuesday (June 2).
Drugmakers worldwide are rushing to develop treatments for the flu-like illness caused by the new coronavirus that has killed more than 374,000 globally since it first emerged late last year in China.
Limited time offer:
Just RM5 per month.
